Log in
Enquire now
‌

US Patent 10568848 Treatment of autism with cannabidiol

Patent 10568848 was granted and assigned to Zynerba Pharmaceuticals on February, 2020 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
Zynerba Pharmaceuticals
Zynerba Pharmaceuticals
0
Current Assignee
Zynerba Pharmaceuticals
Zynerba Pharmaceuticals
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
105688480
Patent Inventor Names
Donna Gutterman0
Marcel Bonn-Miller0
Terri Sebree0
Date of Patent
February 25, 2020
0
Patent Application Number
164112480
Date Filed
May 14, 2019
0
Patent Citations Received
‌
US Patent 12121617 Transdermal delivery of cannabidiol
0
‌
US Patent 11779549 Treatment of Fragile X Syndrome with cannabidiol
‌
US Patent 12016829 Pharmaceutical composition and method for treating seizure disorders
0
‌
US Patent 11458110 Treatment of Fragile X Syndrome with cannabidiol
Patent Primary Examiner
‌
Michael V Meller
0
Patent abstract

The present technology relates to a method of treating one or more behavioral symptoms of Autism Spectrum Disorder (ASD) in a subject by transdermally administering an effective amount of cannabidiol (CBD) to the subject wherein one or more behavioral symptoms of ASD are treated in the subject.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 10568848 Treatment of autism with cannabidiol

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us